Raloxifene

• CAT Number: R044961
• CAS Number: 84449-90-1
• Molecular Formula: C28H27NO4S
• Molecular Weight: 473.59
• Purity: ≥95%
• Synonyms: Keoxifene; LY 139481; [2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone
• Target: Estrogen Receptor/ERR
• Storage: Desiccate at RT
• IUPAC Name: [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
• InChI: InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2
• InChIKey: GZUITABIAKMVPG-UHFFFAOYSA-N
• SMILES: C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O

Raloxifene (Cat No.:R044961), also known as Keoxifene; LY 139481; [2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone; Raloxifenine, etc. Raloxifen has estrogen agonistic effect in bone and cardiovascular system, and estrogen antagonistic effect in uterus and breast. It can be used to prevent and treat osteoporosis in postmenopausal women, improve menopausal symptoms of postmenopausal women, and has potential cardiovascular protection.